Cargando…
A designed cyclic analogue of gomesin has potent activity against Staphylococcus aureus biofilms
BACKGROUND: Infections caused by bacterial biofilms are very difficult to treat. The use of currently approved antibiotics even at high dosages often fails, making the treatment of these infections very challenging. Novel antimicrobial agents that use distinct mechanisms of action are urgently neede...
Autores principales: | Dias, Susana A, Pinto, Sandra N, Silva-Herdade, Ana S, Cheneval, Olivier, Craik, David J, Coutinho, Ana, Castanho, Miguel A R B, Henriques, Sónia T, Veiga, Ana Salomé |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704431/ https://www.ncbi.nlm.nih.gov/pubmed/36171717 http://dx.doi.org/10.1093/jac/dkac309 |
Ejemplares similares
-
Quantitative
Imaging of the Action of vCPP2319, an
Antimicrobial Peptide from a Viral Scaffold, against Staphylococcus
aureus Biofilms of a Clinical Isolate
por: Dias, Susana A., et al.
Publicado: (2023) -
The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms
por: Pinto, Sandra N, et al.
Publicado: (2019) -
Unlocking the Potential of the Antimicrobial Peptide Gomesin: From Discovery and Structure–Activity Relationships to Therapeutic Applications
por: Liu, Xiaorong, et al.
Publicado: (2023) -
Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties
por: Vernen, Felicitas, et al.
Publicado: (2019) -
The antiproliferative and apoptotic profile of gomesin against DFTD
por: Ikonomopoulou, Maria P., et al.
Publicado: (2018)